Astorg
About Astorg
Astorg is a private equity firm with offices across Europe and the United States that partners with entrepreneurs and management teams to drive growth. The firm focuses on investments in software, healthcare, business services and technology-based industrial companies, seeking value through strategic governance, disciplined capital allocation and value-creating initiatives. With a long-term, collaborative approach, Astorg aims to align management and shareholders to execute transformative plans. Headquartered in Europe with a global presence, Astorg emphasizes listening to leadership to uncover true value and sustainable returns.
Recent News
EXCLUSIVE: Astorg Portco Steliau to Acquire H2’s Acal BFI
Astorg-Backed IPCOM to Acquire a Majority Stake in Le Froid Pecomark
CordenPharma to Acquire AmbioPharm, Adding 400‑Person Peptide CDMO to Global Platform
Astorg to Acquire Thermo Fisher’s Microbiology Unit for $1.1 Billion
Thermo Fisher Scientific to Sell Microbiology Business to Astorg for $1.075bn
High Revenues, Long-Term Prospects Draw PE to Industrials; Thoma Bravo Featured in They Said It
CordenPharma to Acquire AmbioPharm, Adding U.S. and China Peptide Capacity
Astorg Eyes ‘Wealth of Opportunities’ for Thermo Fisher Microbiology Biz; Mid-Market Firms Poised to Back Pharmacies
J.C. Flowers’ Peter Yordán and FTV Capital’s Kyle Griswold Talk Financial Services Investing; LongRange to Buy Pizza Hut; Clario Exit in Depth
Hg-Backed Gen II Weighs Potential $6bn Sale
Cint Shares Jump as Triton-Backed Consortium Launches Take-Private Bid